- Home
- EDSA vs ISPO Comparison
EDSA vs ISPO Comparison
Compare EDSA & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- ISPO
- Stock Information
- Founded
- EDSA 2015
- ISPO 2010
- Country
- EDSA Canada
- ISPO United States
- Employees
- EDSA N/A
- ISPO N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- ISPO Blank Checks
- Sector
- EDSA Health Care
- ISPO Finance
- Exchange
- EDSA Nasdaq
- ISPO Nasdaq
- Market Cap
- EDSA 13.8M
- ISPO 13.4M
- IPO Year
- EDSA N/A
- ISPO N/A
- Fundamental
- Price
- EDSA $4.06
- ISPO $3.85
- Analyst Decision
- EDSA Strong Buy
- ISPO Buy
- Analyst Count
- EDSA 2
- ISPO 2
- Target Price
- EDSA $39.00
- ISPO $10.50
- AVG Volume (30 Days)
- EDSA 12.3K
- ISPO 35.8K
- Earning Date
- EDSA 08-09-2024
- ISPO 11-04-2024
- Dividend Yield
- EDSA N/A
- ISPO N/A
- EPS Growth
- EDSA N/A
- ISPO N/A
- EPS
- EDSA N/A
- ISPO N/A
- Revenue
- EDSA N/A
- ISPO $300,935,000.00
- Revenue This Year
- EDSA N/A
- ISPO N/A
- Revenue Next Year
- EDSA N/A
- ISPO N/A
- P/E Ratio
- EDSA N/A
- ISPO N/A
- Revenue Growth
- EDSA N/A
- ISPO N/A
- 52 Week Low
- EDSA $2.50
- ISPO $3.11
- 52 Week High
- EDSA $8.33
- ISPO $9.31
- Technical
- Relative Strength Index (RSI)
- EDSA 42.54
- ISPO 47.41
- Support Level
- EDSA $4.13
- ISPO $3.65
- Resistance Level
- EDSA $4.44
- ISPO $4.07
- Average True Range (ATR)
- EDSA 0.22
- ISPO 0.25
- MACD
- EDSA -0.01
- ISPO -0.03
- Stochastic Oscillator
- EDSA 6.90
- ISPO 28.87
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About ISPO Inspirato Incorporated
Inspirato Inc is a luxury travel subscription luxury travel company that provides exclusive access to a managed and controlled portfolio of curated vacation options, delivered through a model designed to ensure the service, certainty, and value that discerning customers demand. The Inspirato portfolio includes branded luxury vacation homes, accommodations at five-star hotel and resort partners, and custom travel experiences. It has a geographic location in the United States and Outside the United States. It generates the majority of its revenue from the United States.